Back to Directory

Phenylpiracetam

Phenotropil, Carphedon, Fonturacetam

Visual ViewRaw DataInteraction Data

Meta Information

ID:phenylpiracetam
Name:
Schema Version:AIM-2.0

Interactions

Target id:
/class/stimulants
Target name:
Stimulant Medications
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Phenylpiracetam has significant psychostimulant properties that add to the effects of other stimulants (e.g., amphetamines, methylphenidate), increasing the risk of overstimulation, anxiety, insomnia, and cardiovascular side effects like hypertension and tachycardia.
Actionable advice:
Avoid co-administration with other stimulant medications unless under strict medical supervision.
Target id:
/class/maois
Target name:
Monoamine Oxidase Inhibitors (MAOIs)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Phenylpiracetam may increase dopamine levels, and co-administration with MAOIs could theoretically lead to a hypertensive crisis or serotonin syndrome due to excessive monoamine accumulation.
Actionable advice:
Avoid using phenylpiracetam with MAOIs completely.
Target id:
/condition/seizure-disorder
Target name:
Seizure Disorder / Epilepsy
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
While some research suggests anticonvulsant properties, its primary stimulant effects may lower the seizure threshold in susceptible individuals, potentially counteracting the efficacy of anticonvulsant medications or provoking seizures.
Actionable advice:
Avoid use if you have a history of seizures or epilepsy unless cleared by a neurologist.
Target id:
/condition/bipolar-disorder
Target name:
Bipolar Disorder
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The potent stimulant and dopaminergic effects of phenylpiracetam can potentially induce mania or hypomania in individuals with bipolar disorder.
Actionable advice:
Avoid use if you have bipolar disorder, especially without consulting a psychiatrist.
Target id:
/condition/psychosis-history
Target name:
History of Psychosis
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
As a dopaminergic stimulant, phenylpiracetam may exacerbate or trigger psychotic symptoms in individuals with a personal or family history of psychotic disorders.
Actionable advice:
Avoid use if you have a personal or strong family history of psychosis.
Target id:
/condition/cardiovascular-disease
Target name:
Cardiovascular Disease
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The stimulant properties of phenylpiracetam can increase blood pressure and heart rate, which may pose a significant risk for individuals with pre-existing cardiovascular conditions like hypertension, arrhythmias, or coronary artery disease.
Actionable advice:
Avoid use if you have a history of significant cardiovascular disease or uncontrolled hypertension.
Target id:
/condition/pregnancy
Target name:
Pregnancy
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The safety of phenylpiracetam during pregnancy has not been established, and its use is contraindicated due to unknown risks to fetal development.
Actionable advice:
Avoid completely if you are pregnant.
Target id:
/condition/lactation
Target name:
Breastfeeding (Lactation)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
It is unknown if phenylpiracetam is excreted in breast milk, and its stimulant properties could be harmful to a nursing infant.
Actionable advice:
Avoid completely if you are breastfeeding.
Target id:
/circadian/sleep
Target name:
Going to Sleep
Severity:
major
Interaction type:
adverse
Nature:
temporal
Temporal spacing:
Hours before target:
8
Hours after target:
null
Description:
Phenylpiracetam is a potent psychostimulant with a half-life of 3-5 hours that can significantly delay sleep onset, reduce sleep quality, and cause insomnia if taken too close to bedtime.
Actionable advice:
Take your dose in the morning and avoid taking it within 8 hours of your planned bedtime.
Target id:
/intervention/caffeine
Target name:
Caffeine
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The stimulant effects of phenylpiracetam can be potentiated by caffeine, leading to an increased risk of jitteriness, anxiety, heart palpitations, and insomnia.
Actionable advice:
Use caution and consider reducing or eliminating caffeine intake when using phenylpiracetam.
Target id:
/class/dopaminergic-agents
Target name:
Dopaminergic Medications
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Phenylpiracetam can increase the density of dopamine D2 receptors, potentially amplifying the effects and side effects (e.g., dyskinesias, psychiatric symptoms) of other dopaminergic medications like L-DOPA or dopamine agonists.
Actionable advice:
Use with caution and under medical supervision when combined with other dopaminergic drugs.
Target id:
/intervention/alcohol
Target name:
Alcohol
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Combining the stimulant effects of phenylpiracetam with the depressant effects of alcohol can mask the feeling of intoxication, potentially leading to excessive alcohol consumption and unpredictable behavioral effects.
Actionable advice:
Avoid consuming alcohol while using phenylpiracetam.
Target id:
/condition/renal-impairment
Target name:
Renal Impairment
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Phenylpiracetam is primarily cleared by the kidneys, and impaired renal function can lead to its accumulation in the body, increasing the risk and severity of side effects.
Actionable advice:
Use with caution and consider dose reduction if you have kidney disease; consult your physician.
Target id:
/condition/long-term-daily-use
Target name:
Long-Term Daily Use
Severity:
moderate
Interaction type:
diminishing
Nature:
absolute
Temporal spacing:
null
Description:
Continuous daily use of phenylpiracetam can lead to rapid pharmacological tolerance, diminishing its stimulant and nootropic effects over time.
Actionable advice:
To prevent tolerance, use phenylpiracetam cyclically (e.g., a few days on, a few days off) rather than daily.
Target id:
/class/choline-precursors
Target name:
Choline Precursors
Severity:
moderate
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
Phenylpiracetam may increase the brain's demand for acetylcholine; co-administration with a choline precursor can support acetylcholine synthesis, potentially enhancing cognitive benefits and preventing associated headaches.
Actionable advice:
Consider taking a choline source like Alpha-GPC or Citicoline concurrently with phenylpiracetam.
Target id:
/circadian/wake
Target name:
Waking Up
Severity:
moderate
Interaction type:
synergistic
Nature:
temporal
Temporal spacing:
Hours before target:
null
Hours after target:
2
Description:
Taking phenylpiracetam in the morning aligns its stimulant and cognitive-enhancing effects with the body's natural wakefulness cycle, maximizing benefits and minimizing sleep disruption.
Actionable advice:
Take your daily dose within two hours of waking up for optimal effect.
Target id:
/dietary/meal
Target name:
Any Caloric Meal
Severity:
minor
Interaction type:
diminishing
Nature:
temporal
Temporal spacing:
Hours before target:
0.5
Hours after target:
1
Description:
Taking phenylpiracetam with food may slightly delay its absorption and the onset of its effects, though it does not significantly impact overall bioavailability.
Actionable advice:
For a faster onset of action, take on an empty stomach 30 minutes before a meal or 1 hour after.
Target id:
/condition/hepatic-impairment
Target name:
Hepatic Impairment
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
While not extensively metabolized by the liver, severe hepatic impairment could alter drug disposition, so caution is warranted.
Actionable advice:
Consult a physician before use if you have significant liver disease.